| 【Company Research】Momo (MOMO US) – Mixed 1Q20; Cautious on ST recovery pace |
| 【Company Research】CSPC Pharmaceutical (1093 HK) – Inline 1Q results amid COVID-19 outbreak |
| 【公司研究】滔搏 (6110 HK) – 7月起業務將重回正軌 |
| 【Company Research】Meituan Dianping (3690 HK) – Faster recovery ahead with expanding TAM |
| 【Company Research】Alibaba (BABA US) – Better-than-expected ecommerce recovery |
| 【Company Research】Pinduoduo (PDD US) – More bullish on topline growth |
| 【Company Research】Tongcheng-Elong (780 HK) – Moving to 2H20E recovery |
| 【Company Research】JOYY Inc. (YY US) – More bullish on Bigo’s overseas expansion |
| 【Company Research】Mengniu (2319 HK) – Sales recovery ahead of expectation |
| 【Sector Research】China Healthcare Sector – The race for a COVID-19 vaccine |